AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company operates through two primary segments: BioPharmaceuticals and Oncology.
AstraZeneca was founded on April 6, 1999, through the merger of Astra AB and Zeneca Group PLC and is headquartered in Cambridge, United Kingdom.
AstraZeneca is involved in the development of medications across a wide range of medical disciplines. Its key areas of focus include respiratory, cardiovascular, renal and metabolism, and oncology.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Pascal Soriot D.V.M., M.B.A. | CEO & Executive Director | 4.78M | N/A | 1959 |
| Dr. Aradhana Sarin M.D. | CFO & Executive Director | 2.73M | N/A | 1975 |
| Ms. Pam P. Cheng | EVP of Global opt. & IT, Chief Sust. Officer and Member of External Sust.Adv. Board | N/A | N/A | 1971 |
| Mr. Andrew P. Barnett | Head of Investor Relations | N/A | N/A | N/A |
| Mr. Jeffrey Pott | CHRO, Chief Compliance Officer, General Counsel & Member of External Sustainability Advisory Board | N/A | N/A | N/A |
| Gonzalo Vina | Head of Global Media Relations | N/A | N/A | N/A |
| Dr. Menelas Pangalos Ph.D. | EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board | N/A | N/A | 1967 |
| Dr. Ruud Dobber Ph.D. | Executive Vice-President of BioPharmaceuticals Business Unit | N/A | N/A | N/A |
| Dr. Susan Mary Galbraith M.D., Ph.D. | Executive Vice President of Oncology Research & Development | N/A | N/A | 1966 |
| Mr. Leon Wang | Executive VP of International & China President | N/A | N/A | N/A |
Charts and financial information provided by TradingView, a popular charting & trading platform.
Check out even more advanced features or grab charts for your website.
This post has been viewed 4 times.
